Akira Kawamura to Coronary Restenosis
This is a "connection" page, showing publications Akira Kawamura has written about Coronary Restenosis.
Connection Strength
1.014
-
Kawamura A, Miura S, Fujino M, Nishikawa H, Matsuo Y, Tanigawa H, Tomita S, Tsuchiya Y, Matsuo K, Saku K. CXCR3 chemokine receptor-plasma IP10 interaction in patients with coronary artery disease. Circ J. 2003 Oct; 67(10):851-4.
Score: 0.239
-
Sugihara M, Miura S, Nishikawa H, Ike A, Mori K, Iwata A, Kawamura A, Saku K. Characteristics of patients and types of lesions in patients with drug-eluting or bare-metal stent implantation in small coronary arteries: from the FU-Registry. J Cardiol. 2013 Feb; 61(2):117-21.
Score: 0.113
-
Mito T, Miura S, Iwata A, Morii J, Sugihara M, Ike A, Mori K, Kawamura A, Nishikawa H, Zhang B, Saku K. Determination of the cut-off plasma adiponectin level associated with a lower risk of restenosis in patients with stable angina. Coron Artery Dis. 2011 Nov; 22(7):451-7.
Score: 0.105
-
Kuwano T, Miura S, Shirai K, Ike A, Mori K, Shimizu T, Zhang B, Iwata A, Nishikawa H, Kawamura A, Saku K. Serum levels of bilirubin as an independent predictor of coronary in-stent restenosis: a new look at an old molecule. J Atheroscler Thromb. 2011; 18(7):574-83.
Score: 0.100
-
Takamiya Y, Miura S, Tsuchiya Y, Fukuda Y, Zhang B, Kuwano T, Ike A, Yanagi D, Kubota K, Mori K, Iwata A, Nishikawa H, Kawamura A, Miller N, Matsuo K, Shirai K, Saku K. Angiographic late lumen loss at the site of overlap of multiple Cypher? sirolimus-eluting stents: ALSOCE study. J Cardiol. 2011 Mar; 57(2):187-93.
Score: 0.099
-
Takamiya Y, Miura S, Kawamura A, Tanigawa H, Zhang B, Iwata A, Nishikawa H, Matsuo K, Shirai K, Saku K. Intensive LOwering of BlOod pressure and low-density lipoprotein ChOlesterol with statin theraPy (LOBOCOP) may improve neointimal formation after coronary stenting in patients with coronary artery disease. Coron Artery Dis. 2009 Jun; 20(4):288-94.
Score: 0.089
-
Iwata A, Miura S, Shirai K, Kawamura A, Tomita S, Matsuo Y, Zhang B, Nishikawa H, Kumagai K, Matsuo K, Saku K. Lower level of low-density lipoprotein cholesterol by statin prevents progression of coronary restenosis after successful stenting in acute myocardial infarction. Intern Med. 2006; 45(15):885-90.
Score: 0.073
-
Kawamura A, Miura S, Murayama T, Iwata A, Zhang B, Nishikawa H, Tsuchiya Y, Matsuo K, Tsuji E, Saku K. Increased expression of monocyte CD11a and intracellular adhesion molecule-1 in patients with initial atherosclerotic coronary stenosis. Circ J. 2004 Jan; 68(1):6-10.
Score: 0.061
-
Gondo K, Ike A, Ogawa M, Shirai K, Sugihara M, Nishikawa H, Iwata A, Kawamura A, Mori K, Zhang B, Miura S, Yasunaga S, Saku K. Is a bare-metal stent still useful for improving the outcome of percutaneous coronary intervention? From the FU-Registry. J Cardiol. 2017 04; 69(4):652-659.
Score: 0.036
-
Nagata I, Ike A, Nishikawa H, Zhang B, Sugihara M, Mori K, Iwata A, Kawamura A, Shirai K, Uehara Y, Ogawa M, Miura S, Saku K. Associations between lipid profiles and MACE in hemodialysis patients with percutaneous coronary intervention: from the FU-Registry. J Cardiol. 2015 Feb; 65(2):105-11.
Score: 0.032
-
Ike A, Shirai K, Nishikawa H, Zhang B, Kawamura A, Iwata A, Mori K, Ogawa M, Miura S, Noda K, Saku K. [Series: clinical study from Japan and its reflections; impact of glycemic control on the clinical outcome in diabetic patients with percutaneous coronary intervention:--from the FU-registry--(UMIN registration no. 000005679)]. Nihon Naika Gakkai Zasshi. 2012 Feb 10; 101(2):504-11.
Score: 0.027
-
Miura S, Kawamura A, Saku K. Efficacy and safety of drug-eluting stents in long-term follow-up. Intern Med. 2008; 47(11):987-8.
Score: 0.021
-
Sako H, Miura S, Iwata A, Nishikawa H, Kawamura A, Matsuo K, Shirai K, Saku K. Changes in CCR2 chemokine receptor expression and plasma MCP-1 concentration after the implantation of bare metal stents versus sirolimus-eluting stents in patients with stable angina. Intern Med. 2008; 47(1):7-13.
Score: 0.020